ED vs EWTX · P/E 18, rev $15.26B vs $3.75B cap
Consolidated Edison Inc (ED) versus Edgewise Therapeutics Inc (EWTX) — a side-by-side from cached financials, not a winner call.
Consolidated Edison Inc (ED) is a utilities - regulated electric company listed on US.
Edgewise Therapeutics Inc (EWTX) is a biotechnology company listed on NASDAQ.
Latest reported ED revenue for 2024-12-31 was $15.26B. Net income was $1.82B. Revenue was up 4.0% from 2023-12-31 to 2024-12-31. ED currently screens at market cap $36.02B and trailing P/E 18.3.
EWTX does not have a complete income-statement cache yet.
ED currently screens at market cap $36.02B and trailing P/E 18.3. EWTX currently screens at market cap $3.75B.
Not investment advice. Open the ED and EWTX stock pages for the full models.
Not investment advice.